Public Health Genomics

简称 PUBLIC HEALTH GENOM ·SWITZERLAND ·出版周期 Bimonthly ·年均收录 41 篇

1.5

最新影响因子

7.90%

自引率

较易

投稿难度

>12周，或约稿

审稿周期

期刊简介

Public Health Genomics是一本专注于公共卫生与基因组学交叉领域的学术期刊，ISSN号为1662-4246，由瑞士的Karger出版社出版，出版周期为双月刊，出版地也在瑞士。该期刊的影响因子根据年份有所不同，具体数值需查阅最新JCR报告，它属于开放获取（OA）期刊，并被SCI收录，中科院分区情况需参考最新分区表。杂志的发文特点集中于基因组学在公共卫生领域的应用研究，涵盖疾病预防、健康政策、遗传流行病学及精准医学等方向，旨在促进基因组技术向公共卫生实践的转化。其质量表现为审稿严谨、内容前沿，但作为OA期刊可能存在一定的出版费用风险，同时因学科交叉性强，读者群体相对专业，影响力可能局限于特定领域。总体而言，该期刊为公共卫生基因组学研究提供了重要的学术交流平台。

影响因子趋势

近期发表

Survivors’ Responses to an Online Intervention to Promote Discussions of Cancer Genetic Risk with Blood Relatives 2026-08-18

Opportunities and Challenges in Translating Genomics into Population Health Impact: Lessons from Familial Hypercholesterolemia 2026-07-21

What Is at Stake in Genetic Newborn Screening for Rare Diseases? An Exploratory Qualitative Study of Parents’ and Expectant Parents’ Concerns in the Screen4Care Project 2026-07-14

“I Know that One Day I Will Be Cured”: Perspectives on Acceptability of Curative Therapies for Sickle Cell Disease in Tanzania 2026-07-07

Optimizing Reporting and Outreach for Surveillance and Risk-Reducing Surgeries for Cancer Genetic Predisposition: Findings of a Workshop Organized by the International Cascade Consortium 2026-06-29

Key Outcomes from a Stakeholder Workshop on Genomic Newborn Screening: Recommended Next Steps for the Integration of Genomics into Public Health Programs 2026-06-27

The IMPACT-FH Renewal Protocol: Evaluating FH Cascade Testing Implementation in Primary Care through a Pragmatic Trial, Economic Evaluation, and Mixed-Methods Sustainability Assessment 2026-06-12

Family Leaders Navigate Burden to Communicate Risk during Cascade Screening after Sudden Cardiac Death in the Young 2026-06-10

Hereditary Hemochromatosis and Hypertrophic Cardiomyopathy as Tier 1 Genomic Conditions: Implications for Adult Population Genomic Screening 2026-06-10

Adolescent and Young Adult Perspectives on Receiving Pathogenic or Likely Pathogenic Results in a Prospective Genomic Screening Clinical Trial 2026-06-09